# 18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism

> **NCT04205604** · PHASE2 · RECRUITING · sponsor: **Miguel Pampaloni** · enrollment: 50 (estimated)

## Conditions studied

- Congenital Hyperinsulinism

## Interventions

- **DRUG:** 18F-Fluoro Dopa Imaging

## Key facts

- **NCT ID:** NCT04205604
- **Lead sponsor:** Miguel Pampaloni
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-11-03
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04205604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04205604, "18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04205604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*